STAT+: China competition, ‘destruction’ at FDA gives agency chance to restructure, Rick Pazdur says

Rick Pazdur, former top oncology regulator at the Food and Drug Administration, stated that recent political appointees have caused significant damage, creating an opportunity for new leadership to restructure the FDA. He highlighted the growing competitiveness of China's drug industry and proposed creative workforce solutions, such as temporarily hiring academics and drug industry professionals.